ADD3

ADD3 encodes gamma-adducin, a membrane-skeletal scaffolding protein homologous to alpha- and beta-adducin that localizes to the spectrin-actin junction of the peripheral membrane skeleton (PMID:8893809, PMID:19425068). In erythroid and other tissues it stabilizes alpha-adducin in a tissue-specific manner, with its loss reducing alpha-adducin levels without exacerbating the beta-adducin-null spherocytosis phenotype, indicating partial functional redundancy among adducin paralogs (PMID:19425068). Through its actin-cytoskeletal scaffolding role, ADD3 supports epithelial barrier organization: in cholangiocytes it is required for recruitment of betaII-spectrin to the membrane, tight junction integrity, transepithelial barrier function, and primary cilia development, and its loss in mice predisposes to severe biliary atresia (PMID:41297070). ADD3 also regulates the myogenic response of resistance arteries by controlling smooth-muscle potassium channel function (PMID:27927653), and modulates glioblastoma stem cell morphology, tumor-tumor connections, cell-cycle progression, and chemoresistance in an actin-dependent manner (PMID:39592188). ADD3 expression is post-transcriptionally controlled, with QKI-5 repressing inclusion of exon 14 to limit lung cancer cell proliferation and migration (PMID:33196842) and multiple miRNAs (miR-145-5p, miR-143-3p) targeting its 3'UTR (PMID:28902846, PMID:37605290). Biallelic ADD3 variants cause a neurodevelopmental syndrome encompassing intellectual disability, microcephaly, and spastic paraparesis/cerebral palsy (PMID:29768408, PMID:36046955).

1. 1996 Medium

   Establishing ADD3 as a third adducin paralog defined its candidate role in membrane-skeletal organization before any function was tested.

   Evidence cDNA cloning, sequence homology analysis, and FISH mapping to 10q24

   PMID:8893809

   Open questions at the time

   • No functional assay or interaction partner demonstrated
   • Tissue distribution beyond Northern blot not characterized
2. 2009 High

   Genetic knockout resolved whether gamma-adducin is functionally redundant, showing it stabilizes alpha-adducin in a tissue-specific way and is dispensable for the spherocytosis phenotype.

   Evidence Add3 knockout mouse with membrane skeleton protein quantification, electron microscopy, and beta/gamma double-null epistasis cross

   PMID:19425068

   Open questions at the time

   • Molecular basis of tissue-specific alpha-adducin stabilization unresolved
   • Direct binding stoichiometry at the spectrin-actin junction not mapped
3. 2016 High

   Knockdown in resistance arteries linked ADD3 to vascular reactivity through potassium channel control, extending its role beyond a passive scaffold.

   Evidence DsiRNA knockdown in ex vivo arteries with pressure myography and potassium current electrophysiology

   PMID:27927653

   Open questions at the time

   • Which potassium channel ADD3 acts on is not identified
   • Whether regulation is direct or via cytoskeletal coupling is unknown
4. 2018 Medium

   Patient variants plus Drosophila genetics established ADD3 as a disease gene and uncovered an epistatic interaction with KAT2B in kidney/heart pathology.

   Evidence Patient variant identification, Drosophila hts rescue and double-RNAi assays, podocyte adhesion/migration assays

   PMID:29768408

   Open questions at the time

   • Mechanism linking ADD3 to KAT2B not defined
   • Causality of individual variants relies partly on fly orthology
5. 2017 Medium

   Identification of miR-145-5p targeting established post-transcriptional control of ADD3 abundance in hepatic stellate cells.

   Evidence Luciferase 3'UTR reporter, miR-145 overexpression/inhibition in LX-2 cells with qPCR and Western blot

   PMID:28902846

   Open questions at the time

   • Functional consequence of ADD3 loss for stellate cell biology not directly tested
   • Single cell-line context
6. 2020 Medium

   Loss-of-function in glioblastoma showed ADD3 restrains tumor growth and angiogenesis, tying its expression to cell-matrix interaction.

   Evidence ADD3 depletion in GBM cells with in vivo tumor assays, Western blot for PCNA/p53/p21/VEGF/VEGFR-2

   PMID:31958485

   Open questions at the time

   • Mechanism connecting ADD3 to p53/p21 and VEGF signaling unresolved
   • Direct molecular partners in this context unknown
7. 2021 High

   Mapping QKI-5 binding to ADD3 pre-mRNA placed exon 14 alternative splicing in a defined tumor-suppressive regulatory pathway.

   Evidence iCLIP-seq binding mapping, splicing assays, QKI-5 perturbation, proliferation/migration assays

   PMID:33196842

   Open questions at the time

   • Functional difference between exon 14-included and -skipped isoforms at the protein level not defined
   • Whether splice isoforms differ in spectrin/actin binding unknown
8. 2022 Medium

   A biallelic missense variant and neuronal Drosophila assays extended ADD3 disease association to spastic paraparesis/cerebral palsy and established a neuronal requirement.

   Evidence Whole exome sequencing, molecular modelling, Drosophila pan-neuronal overexpression and RNAi with lifespan/locomotion readouts

   PMID:36046955

   Open questions at the time

   • Structural prediction is computational
   • Neuronal molecular role of ADD3 not mechanistically defined
9. 2023 Medium

   A lncRNA-miRNA-ADD3 axis showed ADD3 levels modulate stem cell senescence, proliferation, and migration.

   Evidence Dual-luciferase miR-143-3p/ADD3 3'UTR assay, lncRNA SAN perturbation, EdU/transwell/SA-beta-gal and rescue assays

   PMID:37605290

   Open questions at the time

   • Downstream effectors of ADD3 in senescence not identified
   • Single cell system
10. 2024 Medium

    Necessity-and-sufficiency tests defined ADD3 as an actin-dependent regulator of glioblastoma stem cell morphology, intercellular connectivity, and chemoresistance.

    Evidence ADD3 loss- and gain-of-function in GSCs with live imaging, cell-cycle analysis, chemoresistance and actin perturbation assays

    PMID:39592188

    Open questions at the time

    • Molecular partners mediating tumor-tumor connections unknown
    • Relationship to its membrane-skeletal scaffolding role unclear
11. 2025 High

    Human organoid plus mouse knockouts established ADD3 as essential for cholangiocyte differentiation, betaII-spectrin recruitment, ciliogenesis, and epithelial barrier integrity, linking its scaffolding function to biliary atresia susceptibility.

    Evidence ADD3 knockout cholangiocyte organoids with TEER and immunofluorescence, electron microscopy of bile ducts, Add3 knockout mouse RRV-induced biliary atresia model

    PMID:41297070

    Open questions at the time

    • How ADD3 directs betaII-spectrin recruitment mechanistically not resolved
    • Connection between cilia defect and barrier failure not dissected

• It remains unknown how the single ADD3 scaffolding activity is mechanistically partitioned across its diverse roles in membrane-skeleton stabilization, ion-channel regulation, epithelial barrier/cilia formation, and tumor cell behavior.
• No structural model of ADD3 at the spectrin-actin junction in the corpus
• Direct molecular substrates/effectors largely undefined
• Isoform-specific functions not connected to phenotypes